Australia's Patrys jumps most in nearly 2 weeks on U.S. patent grant
31/03/2021 04:44
** Shares of cancer treatment specializer Patrys Ltd
PAB.AX add as much as 14.8% to A$0.031, their biggest intraday
pct gain since March 18
** Patrys says a patent covering use of co's deoxymabs
assets has been granted in the United States urn:newsml:reuters.com:*:nASX4JcGsR
** Deoxymabs penetrate cancer cells and disrupt their DNA
damage repair systems and has proven to be effective for
treating certain cancers
** About 9.5 mln shares change hands, vs the 30-day avg
volume of 7.1 mln
** Stock up 12.5% this year, as of last close
(Reporting by Yamini C S)
((Yamini.CS@thomsonreuters.com;))